Most Recent

Contributors

March 1, 2012

Meet some of the people featured in the March 2012 issue of The Scientist.

0 Comments

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Delivering Silence

Delivering Silence

By | March 1, 2012

Using RNA viruses to silence genes could optimize tissue targeting while reducing toxicity.

0 Comments

image: Electron Microscopy Through the Ages

Electron Microscopy Through the Ages

By | March 1, 2012

Take a tour through the revolutionary menthod's past, present, and future.

8 Comments

image: One Year On

One Year On

By | March 1, 2012

Some thoughts about the ecological fallout from Fukushima

0 Comments

image: Promoting Death

Promoting Death

By | March 1, 2012

Editor's choice in biochemistry

0 Comments

image: The Subcellular World Revealed, 1945

The Subcellular World Revealed, 1945

By | March 1, 2012

The first electron microscope to peer into an intact cell ushers in the new field of cell biology.

4 Comments

image: Ovarian Stem Cells in Humans?

Ovarian Stem Cells in Humans?

By | February 27, 2012

Adult human ovaries contain a population of stem cells capable of generating immature egg cells.

7 Comments

image: Climate Conflict of Interest?

Climate Conflict of Interest?

By | February 24, 2012

Greenpeace flags researchers' payments from a climate change skeptic organization.

0 Comments

image: New Kind of Cellular Suicide

New Kind of Cellular Suicide

By | February 23, 2012

Researchers identify a gene that drives a type of cellular suicide that differs from the more commonly observed apoptosis phenomenon.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech